Analyst Ratings for Marrone Bio Innovations (MBII)

MBII Rating Summary

  |   Expand Research on MBII
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 6.3 / 10   Percentile Rank: 67%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/17/2022 Canaccord Bobby Burleson Downgrade Hold
(Buy)		 1.30
(N/A)		 0.70
(0.80)		 14.29% Details
9/22/2021 Roth/MKM Gerry Sweeney New Coverage Buy
(N/A)		 2.00
(N/A)		 0.82
(0.80)		 -2.44% Details